Of the original group, 676 people underwent a repeat examination 5 years later. At the time of the initial exam, 49% had at least one cyst ≥ 2 mm in diameter. The yearly incidence of new cysts during ...

When it comes to early detection of silent but deadly diseases like pancreatic cancer, finding it early and predicting disease aggressiveness are critical for increasing long-term survival. With no ...

Using tiny cameras, Somashekar Krishna, MD, and his team at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute are able to ...

Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to extract and analyze specific data points from the magnetic resonance ...

A late-stage trial found a new pill, daraxonrasib, doubled median survival and improved quality of life, compared with ...

Doctors at UVA Health are using a new method to treat pancreatic cysts, which are collections of fluid that form in the pancreas. Some cysts can eventually become cancerous, and typically need surgery ...

The ever-increasing use of radiographic imaging of the abdomen, in particular by CT and MRI, has led to a significant rise in the discovery of patients with pancreatic cysts. Often these are ...

Pancreatic cystic neoplasms (PCNs) are a complex group of lesions with a spectrum of malignancy. Accurate differentiation of PCN types is crucial for patient management, as misdiagnosis can result in ...

Mass General Brigham study of more than 6,000 patients highlights the need for long-term personalized surveillance strategies Catching pancreatic cancer early can increase the five-year survival rate ...

Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to extract and analyze specific data points from the Magnetic Resonance ...

The American Cancer Society predicts that 66,440 people in 2024 will be diagnosed with pancreatic cancer, and 51,750 people will die of pancreatic cancer by the end of the year. In Louisiana, cancer ...

PARSIPPANY, NJ, July 29, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX: IDXG) today responded to the undefined ...